Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-11-2022 | Infliximab | Case report

Infliximab/sulfasalazine/unspecified steroid

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Choong CL, et al. Screening for tuberculosis and its outcome on pediatric inflammatory bowel disease. Journal of Gastroenterology and Hepatology 37 (Suppl. 1): 152-154 abstr. 247, Sep 2022. Available from: URL: http://doi.org/10.1111/jgh.15953 [abstract] Choong CL, et al. Screening for tuberculosis and its outcome on pediatric inflammatory bowel disease. Journal of Gastroenterology and Hepatology 37 (Suppl. 1): 152-154 abstr. 247, Sep 2022. Available from: URL: http://​doi.​org/​10.​1111/​jgh.​15953 [abstract]
Metadata
Title
Infliximab/sulfasalazine/unspecified steroid
Lack of efficacy: case report
Publication date
01-11-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-27114-y

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Tozinameran

Case report

Prednisolone